Key Takeaways
- Fermi shares plummeted approximately 16.6%, starting the day at $6.15 compared to the previous $7.32 close, with trading volume surpassing 22 million shares
- The firm announced an expanded $375M convertible senior notes offering carrying a 5.00% interest rate and maturing in 2031, potentially reaching $431.25M in total
- The conversion threshold sits at roughly $9.52 per share, triggering significant dilution concerns throughout the investor community
- The company disclosed a net loss of approximately $189M for Q1 2026 while generating no revenue, falling short of Wall Street projections
- Company insiders have offloaded more than 1 million shares over the past three months, totaling around $7.3M in value
Shares of Fermi (FRMI) experienced a steep decline of approximately 16.6% during Friday’s trading session following Thursday evening’s announcement of a $375 million convertible senior notes offering. The stock kicked off trading at $6.15, significantly below Thursday’s closing price of $7.32, and hovered near $6.19 with exceptional trading activity exceeding 22 million shares.
The debt instruments feature a 5.00% annual interest rate with a 2031 maturity date. The notes were marketed exclusively to qualified institutional buyers in accordance with Rule 144A regulations. The initial purchasers secured an option to acquire an extra $56.25 million worth of notes, which could push the aggregate offering size to $431.25 million.
Management established the conversion threshold at approximately $9.52 per share. The company indicated plans to allocate a portion of the capital raised toward financing capped call transactions, a strategic mechanism intended to mitigate dilution effects for current shareholders up to $14.64 per share.
However, the market response was decidedly negative. The significant dilution potential facing a stock already experiencing downward momentum triggered an immediate and substantial sell-off that commenced during after-hours trading Thursday and extended through Friday’s regular session.
First Quarter Results Compound Concerns
The financing announcement arrives amid an already challenging operational backdrop. Fermi disclosed a net loss of roughly $189 million during the first quarter of 2026, predominantly attributed to non-cash share-based compensation expenses. The company recorded zero revenue throughout the three-month period, completely missing Wall Street expectations.
This disappointing performance catalyzed a series of analyst downgrades across the Street. Evercore moved Fermi from “outperform” to “in-line.” Wall Street Zen downgraded the stock from “hold” to “sell.” Stifel Nicolaus dramatically reduced its price objective from $29.00 down to $17.00, while maintaining a “buy” recommendation. Weiss Ratings confirmed its “sell (d-)” stance as recently as July 2.
The analyst consensus currently registers as “Moderate Buy” with a mean price target of $22.44 — substantially above current trading levels.
Management stated that capital from the notes offering will support Project Matador, the company’s gigawatt-scale artificial intelligence power facility located in Amarillo, Texas.
Executive Stock Sales Heighten Uncertainty
Insider transaction patterns have done little to inspire confidence. Director James Richard Perry divested 863,637 shares on June 30 at an average execution price of $7.31, representing a transaction valued at more than $6.3 million. This disposition decreased his stake by 5.17%.
Additionally, insider Mesut Uzman sold 79,509 shares on June 3 at $6.31 apiece. Collectively, company insiders have liquidated over 1 million shares during the previous 90-day window, representing approximately $7.3 million in aggregate value.
Cantor Fitzgerald launched coverage in April with an “overweight” rating and an $8.00 price objective — representing one of the more conservative bullish perspectives among covering analysts.
The stock reached a 52-week peak of $36.99. Friday’s trading session pushed FRMI closer to $6.19, dangerously near its 52-week bottom of $4.47. The convertible notes transaction is scheduled to finalize on July 14, 2026.
